The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Japanese Encephalitis Virus Vaccine Market Research Report 2025
Synopsis
Japanese Encephalitis vaccine info for parents, public, and healthcare professionals.
The global Japanese Encephalitis Virus Vaccine market was valued at US$ 408.6 million in 2023 and is anticipated to reach US$ 572.2 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Japanese Encephalitis Virus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Japanese Encephalitis Virus Vaccine.
Report Scope
The Japanese Encephalitis Virus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Japanese Encephalitis Virus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Japanese Encephalitis Virus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Research Foundation for Microbial Diseases of Osaka University
Valneva Austria GmbH
Chengdu Institute
Liaoning Dacheng
Wuhan Institute
Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Japanese Encephalitis Virus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Japanese Encephalitis Virus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Japanese Encephalitis vaccine info for parents, public, and healthcare professionals.
The global Japanese Encephalitis Virus Vaccine market was valued at US$ 408.6 million in 2023 and is anticipated to reach US$ 572.2 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Japanese Encephalitis Virus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Japanese Encephalitis Virus Vaccine.
Report Scope
The Japanese Encephalitis Virus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Japanese Encephalitis Virus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Japanese Encephalitis Virus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Research Foundation for Microbial Diseases of Osaka University
Valneva Austria GmbH
Chengdu Institute
Liaoning Dacheng
Wuhan Institute
Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Japanese Encephalitis Virus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Japanese Encephalitis Virus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Japanese Encephalitis Virus Vaccine Market Overview
1.1 Product Overview and Scope of Japanese Encephalitis Virus Vaccine
1.2 Japanese Encephalitis Virus Vaccine Segment by Type
1.2.1 Global Japanese Encephalitis Virus Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Japanese Encephalitis Virus Vaccine Segment by Application
1.3.1 Global Japanese Encephalitis Virus Vaccine Market Value by Application: (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Japanese Encephalitis Virus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Japanese Encephalitis Virus Vaccine Revenue 2019-2030
1.4.2 Global Japanese Encephalitis Virus Vaccine Sales 2019-2030
1.4.3 Global Japanese Encephalitis Virus Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Japanese Encephalitis Virus Vaccine Market Competition by Manufacturers
2.1 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Japanese Encephalitis Virus Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Japanese Encephalitis Virus Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Product Type & Application
2.7 Japanese Encephalitis Virus Vaccine Market Competitive Situation and Trends
2.7.1 Japanese Encephalitis Virus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Japanese Encephalitis Virus Vaccine Players Market Share by Revenue
2.7.3 Global Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Japanese Encephalitis Virus Vaccine Retrospective Market Scenario by Region
3.1 Global Japanese Encephalitis Virus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Japanese Encephalitis Virus Vaccine Global Japanese Encephalitis Virus Vaccine Sales by Region: 2019-2030
3.2.1 Global Japanese Encephalitis Virus Vaccine Sales by Region: 2019-2024
3.2.2 Global Japanese Encephalitis Virus Vaccine Sales by Region: 2025-2030
3.3 Global Japanese Encephalitis Virus Vaccine Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2019-2030
3.3.1 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2019-2024
3.3.2 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2025-2030
3.4 North America Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.4.1 North America Japanese Encephalitis Virus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Japanese Encephalitis Virus Vaccine Sales by Country (2019-2030)
3.4.3 North America Japanese Encephalitis Virus Vaccine Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.5.1 Europe Japanese Encephalitis Virus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Japanese Encephalitis Virus Vaccine Sales by Country (2019-2030)
3.5.3 Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Japanese Encephalitis Virus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Japanese Encephalitis Virus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Japanese Encephalitis Virus Vaccine Sales by Type (2019-2030)
4.1.1 Global Japanese Encephalitis Virus Vaccine Sales by Type (2019-2024)
4.1.2 Global Japanese Encephalitis Virus Vaccine Sales by Type (2025-2030)
4.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2019-2030)
4.2.1 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2019-2024)
4.2.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2025-2030)
4.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Japanese Encephalitis Virus Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Japanese Encephalitis Virus Vaccine Sales by Application (2019-2030)
5.1.1 Global Japanese Encephalitis Virus Vaccine Sales by Application (2019-2024)
5.1.2 Global Japanese Encephalitis Virus Vaccine Sales by Application (2025-2030)
5.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2019-2030)
5.2.1 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2019-2024)
5.2.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2025-2030)
5.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Japanese Encephalitis Virus Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Research Foundation for Microbial Diseases of Osaka University
6.1.1 Research Foundation for Microbial Diseases of Osaka University Corporation Information
6.1.2 Research Foundation for Microbial Diseases of Osaka University Description and Business Overview
6.1.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Portfolio
6.1.5 Research Foundation for Microbial Diseases of Osaka University Recent Developments/Updates
6.2 Valneva Austria GmbH
6.2.1 Valneva Austria GmbH Corporation Information
6.2.2 Valneva Austria GmbH Description and Business Overview
6.2.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Portfolio
6.2.5 Valneva Austria GmbH Recent Developments/Updates
6.3 Chengdu Institute
6.3.1 Chengdu Institute Corporation Information
6.3.2 Chengdu Institute Description and Business Overview
6.3.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Product Portfolio
6.3.5 Chengdu Institute Recent Developments/Updates
6.4 Liaoning Dacheng
6.4.1 Liaoning Dacheng Corporation Information
6.4.2 Liaoning Dacheng Description and Business Overview
6.4.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Portfolio
6.4.5 Liaoning Dacheng Recent Developments/Updates
6.5 Wuhan Institute
6.5.1 Wuhan Institute Corporation Information
6.5.2 Wuhan Institute Description and Business Overview
6.5.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Product Portfolio
6.5.5 Wuhan Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Japanese Encephalitis Virus Vaccine Industry Chain Analysis
7.2 Japanese Encephalitis Virus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Japanese Encephalitis Virus Vaccine Production Mode & Process
7.4 Japanese Encephalitis Virus Vaccine Sales and Marketing
7.4.1 Japanese Encephalitis Virus Vaccine Sales Channels
7.4.2 Japanese Encephalitis Virus Vaccine Distributors
7.5 Japanese Encephalitis Virus Vaccine Customers
8 Japanese Encephalitis Virus Vaccine Market Dynamics
8.1 Japanese Encephalitis Virus Vaccine Industry Trends
8.2 Japanese Encephalitis Virus Vaccine Market Drivers
8.3 Japanese Encephalitis Virus Vaccine Market Challenges
8.4 Japanese Encephalitis Virus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
